Showing results (51-60 of 212) with videos related to
Sort By:
Pageof 22
Molecular Pharmaceutics|February 5, 2021
Multi-Immune Agonist Nanoparticle Therapy Stimulates Type I Interferons to Activate Antigen-Presenting Cells and Induce Antigen-Specific Antitumor ImmunityElizabeth S Levy, Ryan Chang, Colin R Zamecnik, et al.Clinical Genitourinary Cancer|January 7, 2024
Oral Toxicities of PSMA-Targeted Immunotherapies for The Management of Prostate CancerChitra Priya Emperumal, Alessandro Villa, Caleb Hwang, et al.The Journal of Urology|October 16, 2007
Phase II study of ketoconazole plus granulocyte-macrophage colony-stimulating factor for prostate cancer: effect of extent of disease on outcomeCharles J Ryan, Vivian Weinberg, Jonathan Rosenberg, et al.Oncoimmunology|December 15, 2018
Neoadjuvant sipuleucel-T induces both Th1 activation and immune regulation in localized prostate cancerKatsunobu Hagihara, Stephen Chan, Li Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancerEric J Small, N Simon Tchekmedyian, Brian I Rini, et al.Journal for Immunotherapy of Cancer|May 8, 2020
Combination immunotherapy induces distinct T-cell repertoire responses when administered to patients with different malignanciesJason Cham, Li Zhang, Serena Kwek, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 17, 2025
Expression of Programmed Death-Ligand 1 and Programmed Cell Death-1 Across the Anal Neoplasia Disease Continuum and Association With Survival in Anal CancerSona Chowdhury, Cynthia Gasper, Ann A Lazar, et al.Frontiers in Immunology|January 30, 2020
TCR Convergence in Individuals Treated With Immune Checkpoint Inhibition for CancerTimothy John Looney, Denise Topacio-Hall, Geoffrey Lowman, et al.Cancer Research|December 30, 2016
Immune Toxicities Elicted by CTLA-4 Blockade in Cancer Patients Are Associated with Early Diversification of the T-cell RepertoireDavid Y Oh, Jason Cham, Li Zhang, et al.Cancer Research|May 25, 2016
Clonotypic Diversification of Intratumoral T Cells Following Sipuleucel-T Treatment in Prostate Cancer SubjectsNadeem Sheikh, Jason Cham, Li Zhang, et al.Pageof 22